Early research (Phase 1)UnknownNCT04445038
What this trial is testing
Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
Who this might be right for
add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 52